Diabetic nephropathy affects a subset of about 30% of patients with type 1 Diabetes Mellitus (DM); it also develops in a less defined percentage (20-30%) ofpatients with type 2, after a period of 15-20 years. It is usually divided into stages. The aim of this study is to assess the usefulness of duplex sonography with Doppler wave form analysis in the evaluation of early diabetic nephropathy, in order to detect patients at risk for irreversible renal disease. 262 patients (61 males, 201 females; age range: 48-81 years) with type 2 diabetes mellitus were studied; 100 healthy volunteers with no evidence of diabetes mellitus (74 females, 26 males; age range: 50-80 years) composed the control group. All of them underwent duplex Doppler sonography of the kidneys; a scanner with a 3.5 MHz transducer (Toshiba 270 SSA) was used, Pulsatily Index (P.I.) and Resistive Index (R.I.) of Doppler waveform were obtained at the intrarenal arteries; the average value of 3 bilateral measurements was taken. Doppler sonography was done by the same authors without knowledge of the patient group (case or control). Both indexes (PI. and R.I.) resulted to be higher in patients with DM compared to controls in patients with microalbuminuria: PI.
have to be confirmed by further studies, they suggest that duplex Doppler sonography may be a useful complementary test in the evaluation of diabetic nephropathy, especially in the early stages, in order to identify more patients at risk of developing diabetic nephropathy.
Diabetic nephropathy is the most frequent cause of chronic renal failure: in Italy and in southern Europe it accounts for more than 15-20%, while in northern Europe and in the USA for 30 %; its prevalence is 30% in type I diabetes 10-20 years after the onset of disease and 20-30 % in type 2 diabetes (l). Considering the greatest incidence of the latter, it is clear that most of the diabetic patients with renal failure are oftype 2. Diabetic nephropathy has various stage ofdevelopment. Up to 15 years ago there were no methods capable of identifying patients with early diabetic nephropathy, at a probable reversible stage (2) . Years later a correlation between hypertension and glomerular damage was detected and some indices as nephromegaly, the increased filtration rate and mycroalbuminuria were found to be predictive of evolution in overt nephropathy. Microalbuminuria was firstly considered to be a (3) (4) . Now it is widely believed to be a sign of early stage of disease. In the urine from normal subjects is possible to find a low amount of albumin to a variable rate at different hours of the day and according to physical activity. The threshold value is 30 mg/die (5) . The appearance of mycroalbuminuria in a diabetic patient sometime is concomitant with the onset of hypertension that critically increases the progression of albuminuria and the decline of glomerular filtration (6) . In the last 30 years, studies evaluating renal haemodynamics have dramatically changed, previously being of an invasive type until the coming of ultrasonography (7) .
Color-Doppler ultrasonography has provided a haemodynamic evaluation of renal flow in a totally non-invasive manner. In the kidney, Doppler ultrasound allows an accurate visualization of vasculature. By Doppler US it is possible to obtain evaluations both of qualitative type (presence, direction and type of flow) and quantitative (resistivity and pulsatility index as measure of resistance in the arterious district) (8) . In the past, alterations of renal haemodynamics have been described in the course of diabetic nephropathy at the stage of renal failure. Resistive Index (RI) resulted to be different in normal subjects compared to diabetic patients and in the latter at different creatinin levels; it was concluded that RI represents a predictive index in the advanced stage of diabetic nephropathy (9) .
In diabetic patients there are alterations of arterial vasculature caused by the microvascular damage characteristic of the disease. The first study investigating these alterations was that by Platt in 1989 (10) after which many other authors investigated the microvascular alteration in diabetic nephropathy in order to detect early vascular damage in type 1 and the type 2 diabetes mellitus (11) . The need of a test that could be simple, safe and repeatable, at low cost, useful in detecting diabetic nephropathy at an early stage, has motivated many investigators continue eco-Doppler study of renal flow in diabetic nephropathy (12) (13) .
Microalbuminuria in diabetic patients represent a marker predictive of renal damage, but recent studies point out that when microalbuminuria is present it already implies a structural damage of glomerule in the context of renal and sistemic vascular damage (14) .
The pre-albuminuric stage of diabetic nephropathy can not be evaluated by the use of a laboratory test; when microalbuminuria is detectable, there are pathological lesions, even if at an early stage. In the pre-albuminuric stage there are alterations of zonal hemodynamics with increased intraglomerular pressure (IS).
The aim of this study is to measure these haemodynamic alterations by echo-color-power-Doppler and to confirm the value of RI as marker of early incipient nephropathy.
MATERIALS AND METHODS
The study population consisted of 262 patients (61 males, 201 females; age range: 48-81 years) with type 2 diabetes mellitus, who had been recruited from the Diabetes Outpatient Clinic of our hospital between January 2000 and December 2005. The control group was made up of 100 healthy volunteers with no evidence of diabetes mellitus (74 females, 26 males; age range: 50-80 years). Exclusion criteria for both groups were: current use of tobacco; current or past disease of the kidneys or urinary tract (including cysts, kidney stones, solid tumors, acute or chronic inflammatory diseases); systemic disease with renal involvement; congestive heart failure; arterial hypertension; chronic liver disease; pregnancy; current use of drugs that could affect haemodynamic parameters (e.g. finasteride, nitrates, calcium antagonists, ACE inhibitors, aminophylline, theophylline, estrogenprogestin compounds).
Blood glucose (measured in venous plasma), glycosylated hemoglobin, serum creatinine (all three measured after a fast of 10 h or more), and 24 h urinary excretion of albumin (measured by radioimmunoassay) were measured in all 362 participants. In diabetic patients, three 24-h urine specimens were assayed, and the average of the three results was used for analysis; for control patients, only one 24-h specimen was assayed. Albumin excretion rates of <30 mg/day were considered normal; rates of 30-300 mg/day were classified as microalbuminuria,
Based on the results of these tests, the diabetic patients were divided into three groups: Group I included patients with normal albumin excretion and serum creatinine levels (i.e. <1.3 mg/dL); Group II patients had microalbuminuria with normal serum creatinine levels; and Group III presented microalbuminuria and serum creatinine levels of> 1.3 mg/dL. Moreover, to assess whether this subdivisioninto three groups according to the level of serum creatinine reflected the real difference in value of glomerular filtration rate (GFR), for each patient estimation of GFR was made by the Cockroft-Gault formula (16) . All participants underwent color and power Doppler studies, which were performed with a Toshiba 240SSA scanner and a 3.5-MHz convex probe. The examinations were carried out by two operators who were blinded to the subject's group origins.
After standard sonographic examination of the kidneys and urinary tract, power Doppler was used to determine the RIs and PIs of the intrarenal arteries in each kidney. Resistive Index and Pulsatility Index were calculated according to the following formula:
RI=S-D/S, where S is the height of the systolic peak and D is the height of the end diastolic trough; PI = maximum velocity excursion! mean of the velocity (17) .
The mean ofthree measurements was used for analysis, as recommended by Platt (18) .
SPSS software was used for statistical analysis. Preliminary testing verified that the distribution of the data was normal (KS). For this reason, parametric tests were chosen for inferential analysis of the study variables. The chi square test was used to evaluate differences between qualitative variables. Correlation between variables was assessed with the Pearson correlation coefficient. A P level of p <0.05 was considered significant. Table I , the diabetic and control groups were not significantly different in terms of sex, age, or body-mass indices. Based on the results of enrolment lab work, the 262 diabetic patients were divided into three subgroups: Group I included 145 patients (38 males, 107 females) with normal renal function and no signs of microalbuminuria; Group II included 45 patients (35 males, 10 females) with micro albuminuria but normal renal function; and Group III contained 72 patients (13 males, 59 females) with microalbuminuria and renal insufficiency. The characteristics of these three subgroups are summarized in Table II According to the estimation of GFR by the Cocoroft-Gault formula, the division in the three groups did not change, as reported in Table II The mean age ofGroup I patients was significantly lower than those of the other two groups (p<0.001). The three groups were also significantly different (p<0.001) in terms of the duration of diabetes (years since diagnosis), and this variable was significantly correlated with the severity of the disease. There was no significant difference between the mean values of microalbuminuria in Groups II and III. Glycosylated hemoglobin values were frankly pathological in all three groups, with no significant inter-group differences. Fig. I and 2 show representative scan results for a control subject and a diabetic patient from Group I. As shown in Table III , the mean RIs for the three groups of diabetic patients were all significantly different from that of the control group. The RI for Group I was significantly higher than that of controls (p <0.001) and significantly lower than those of Groups II (p<O.OOI) and III (p<0.0001) (Fig.3) . The difference between the RIs of the latter two groups was also significant (p<0.0001). The PIs ofthe three groups of diabetic patients were also significantly different and increased with the severity of the disease (p<0.001). The difference between the PIs of Group I and the control group was significant (P<0.05) but less so than that of the RIs.
RESULTS

As shown in
The RI displayed significant correlation with the duration of diabetes (p<0.01). Serum creatinine levels displayed a highly significant correlation with RI (R2=0.75) and a slightly less significant correlation with the PI (R2=0.63). Microalbuminuria levels were not significantly related to either of the Doppler indices or to serum creatinine levels. In fact, while the latter three variables (I.R., I.P. and micro albuminuria) all increased progressively from Group 1 to Group 3, this trend was not observed for albumin excretion. The correlation between the RI and PI was highly significant (p<0.001). The duration of diabetes was significantly associated with the haemodynamic parameters and with renal function (as reflected by serum creatinine).
DISCUSSION
Diabetic nephropathy is an important cause of mortality in patients with type-l and type-2 diabetes mellitus. Although much of the work that has been done in this field has focused on renal disease in type 1 diabetes, the pathophysiology of diabetic nephropathy associated with type 2 disease appears to be essentially the same. In both cases, the renal effects of diabetes are related to the macro-and microvascular complications of altered glucose metabolism. In fact, the initial stage of diabetic nephropathy is manifested by functional alterations in renal haemodynamics, which result in glomerular hyperfiltration and increases in the intraglomerular pressure (19) .
There is currently no reliable laboratory marker for detection of diabetic nephropathy in this preclinical phase. The onset of microalbuminuria (>30 mg albumin / day) is widely considered to be the first detectable sign of diabetic damage to the kidney (20) . Its appearance reflects structural damage to the glomerular membrane resulting in loss of its selective permeability. According to some investigators (21) microalbuminuria represents the first step in an inexorable progression to overt proteinuria and renal failure although this view has been challenged by others (22) .
Intraglomerular pressure can not be directly measured in humans, but it can be measured indirectly and in a non-invasive manner by means of color or power Doppler ultrasound studies of the renal vasculature (23) . This approach provides us with quantitative indices of renal vascular resistance based on blood-flow velocities in the intrarenal arteries (24) .
The scope of the present study is to identify changes in renal vascular resistance associated with the onset and progression of diabetic nephropathy. To this end, we performed power Doppler studies of the intrarenal arteries, with calculation of the RI and PI, on 262 type-2 diabetic patients, who were divided into three groups reflecting their renal status. Compared with 100 healthy non-diabetic controls, the Group I diabetics, who had normal creatinine levels and no signs of microalbuminuria, presented significantly higher renal Ris and Pis. Furthermore, additional significant increases in both indices were observed in diabetic patients of Group II, who had microalbuminuria (mean RI: 0.78+/-0.05), and Group III, with microalbuminuria and elevated serum creatinine levels (mean RI: 0.91+/-0.08). Unlike 24 h albumin excretion rates, which were not significantly different in patients from Groups III and III, the RI and PI displayed significantly higher values in patients whose altered albumin excretion rates were accompanied by signs of altered renal function.
Our study indicates that the renal RI and PI increase progressively with the onset and evolution of diabetic nephropathy. The significant differences between the RIs of all three diabetic groups and those of the healthy controls indicate that this parameter can also be used to distinguish normal and diabetic populations, regardless of the latter's stage of disease. The discriminatory power of the IP proved to be slightly lower than that of the RI, in all probability because its calculation is based on the relatively inexact variable, mean blood flow velocity.
These findings suggest that the renal RI might be used as a marker of early (pre-microalbuminuric) renal involvement in type 2 diabetes. It is important to note that the patient and control populations analyzed in this study were carefully selected to minimize the risk of confounding effects on renal vascular resistance due to non-diabetic factors.
Discordant reports have been published on the time of appearance of laboratory changes in diabetics (25) . Nonetheless, microalbuminuria seems to be extremely rare during the first five years of diabetes. Our data confirm this observation and indicate that the duration of the disease is directly correlated with the stage of nephropathy. In fact, the mean number of years from diagnosis increased significantly from Group I through Group III. On the average, microalbuminuria developed approximately seven years after the diabetes was diagnosed, whereas outright renal failure developed only when the diabetes had been present for around 20 years. Group III patients were significantly older than those of Group I but not those of Group II. These differences do not diminish the value of the RI as an index of the severity of diabetic nephropathy although it is clear that intrarenal haemodynamics are physiologically influenced by age.
Glycosylated hemoglobin levels showed no correlation with albumin excretion rates or serum creatinine levels. In fact, there were no significant differences between the mean HbA 1c values observed in the three groups.
In conclusion, although the mean serum creatinine levels and albumin excretion rates of our Group 1 diabetic patients were clearly within normal limits, the RI for this group was significantly higher than those of the non-diabetic control group. This finding suggests that the intrarenal arterial RI might be used as a reliable predictor of latent diabetic renal damage. Compared with albuminuria levels, the RI also appears to be a more sensitive index of the progression of diabetic renal disease. Nonetheless, our findings support the hypothesis that these Doppler indices can be used as markers of early-stage diabetic nephropathy. This does not mean that all of our Group I patients will go on to develop albuminuria and outright renal failure, since the onset and progression of diabetic nephropathy also depends to some extent on genetic and environmental factors alone. The follow-up of these patients will be important to determine the incidence of complications and verify the value of renal RI and PI in identifying early stages of diabetic nephropathy.
